Perbedaan Indofarma Tbk. dan Kian Santang Muliatama Tbk.: Indofarma Tbk. diperdagangkan di Rp126 (kapitalisasi pasar 390,51 M), sedangkan Kian Santang Muliatama Tbk. diperdagangkan di Rp114 (kapitalisasi pasar 163,43 M, volume 24 jam 36,43 jt). Perbedaan utamanya: Indofarma Tbk. jauh lebih besar — sekitar 2,4× kapitalisasi pasar Kian Santang Muliatama Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| INAF | RGAS | |
|---|---|---|
Kapitalisasi Pasar | 390,51 M | 163,43 M |
Volume | — | 36,43 jt |
Lot | — | 364,26 rb |
Perputaran | — | 4 M |
Harga Rata-rata | — | 109,89 |
Nilai Transaksi | — | 4 M |
Harga Ekuilibrium Indikatif | — | 114 |
Volume Ekuilibrium Indikatif | — | 5,9 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Selengkapnya di halaman INAF →PT Kian Santang Muliatama Tbk (the Entity) was established based on the Notarial Deed of Artisa Khamelia Ramadiyanti, S.H., M.Kn., No. 634, dated November 28, 2018. The Entity started its commercial operations on 2019. The controlling party for the Company is Edy Nurhamid Amin.
Selengkapnya di halaman RGAS →